| The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours A Lundberg, LS Lindström, J Li, JC Harrell, E Darai-Ramqvist, EG Sifakis, ... Breast Cancer Research 21, 1-10, 2019 | 61 | 2019 |
| Gene expression signatures and immunohistochemical subtypes add prognostic value to each other in breast cancer cohorts A Lundberg, LS Lindström, JC Harrell, C Falato, JW Carlson, PK Wright, ... Clinical Cancer Research 23 (24), 7512-7520, 2017 | 47 | 2017 |
| The 5-hydroxymethylcytosine landscape of prostate cancer M Sjöström, SG Zhao, S Levy, M Zhang, Y Ning, R Shrestha, A Lundberg, ... Cancer research 82 (21), 3888-3902, 2022 | 22 | 2022 |
| PAM50 provides prognostic information when applied to the lymph node metastases of advanced breast cancer patients NP Tobin, A Lundberg, LS Lindström, JC Harrell, T Foukakis, L Carlsson, ... Clinical Cancer Research 23 (23), 7225-7231, 2017 | 14 | 2017 |
| A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels A Lundberg, LS Lindström, JS Parker, E Löverli, CM Perou, J Bergh, ... Oncogene 39 (32), 5430-5440, 2020 | 11 | 2020 |
| The genomic and epigenomic landscape of double-negative metastatic prostate cancer A Lundberg, M Zhang, R Aggarwal, H Li, L Zhang, A Foye, M Sjöström, ... Cancer Research 83 (16), 2763-2774, 2023 | 7 | 2023 |
| B cell-related gene signature and cancer immunotherapy response A Lundberg, B Li, R Li British Journal of Cancer 126 (6), 899-906, 2021 | 6 | 2021 |
| Intrinsic molecular subtypes of metastatic castration-resistant prostate cancer E Feng, NR Rydzewski, M Zhang, A Lundberg, M Bootsma, KT Helzer, ... Clinical Cancer Research 28 (24), 5396-5404, 2022 | 4 | 2022 |
| Reclassifying tumour cell cycle activity in terms of its tissue of origin A Lundberg, JJJ Yi, LS Lindström, NP Tobin NPJ precision oncology 6 (1), 59, 2022 | 3 | 2022 |
| AR inhibition increases MHC class I expression and improves immune response in prostate cancer LN Chesner, JN Graff, F Polesso, A Smith, A Lundberg, R Das, T Shenoy, ... | 2 | 2023 |
| Transcriptional Gene Signatures: Passing the Restriction Point for Routine Clinical Implementation A Lundberg PQDT-Global, 2019 | 1 | 2019 |
| Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer R Shrestha, LN Chesner, M Zhang, S Zhou, A Foye, A Lundberg, ... Cancer Research 84 (7_Supplement), LB196-LB196, 2024 | | 2024 |
| Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic … X Zhu, DJ Vis, M Sjöström, R Shrestha, J Kneppers, T Severson, Y Zhu, ... Journal of Clinical Oncology 42 (4_suppl), 180-180, 2024 | | 2024 |
| Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer A Lundberg, M Zhang, RR Aggarwal, H Li, L Zhang, A Foye, M Sjöström, ... Cancer Research 83 (11_Supplement), B012-B012, 2023 | | 2023 |
| Abstract B031: Investigation of the ubiquitin ligase RNF31 as a mediator of immune evasion in advanced prostate cancer T Liu, H Li, TJ Hua, H Shin, T Shenoy, M Sjoestroem, A Lundberg, ... Cancer Research 83 (11_Supplement), B031-B031, 2023 | | 2023 |
| Abstract A062: Alternative promoter usage is linked to transcriptional and epigenetic alterations during prostate cancer progression M Zhang, M Sjöström, R Shrestha, A Lundberg, T Moreno-Rodriguez, ... Cancer Research 83 (11_Supplement), A062-A062, 2023 | | 2023 |
| Abstract PR003: Convergent evolution in DNA repair-deficient mCRPC in response to targeted therapy T Moreno, M Zhang, A Lundberg, R Shrestha, M Sjöström, A Pasam, ... Cancer Research 83 (11_Supplement), PR003-PR003, 2023 | | 2023 |
| Abstract A029: Whole genome and transcriptome analysis of paired metastatic biopsies identified resistance mechanisms in castration-resistant prostate cancer X Zhu, D Vis, M Sjöström, R Shrestha, J Kneppers, T Severson, Y Zhu, ... Cancer Research 83 (11_Supplement), A029-A029, 2023 | | 2023 |
| Abstract B041: AR suppresses MHC Class I expression and T-cell response in prostate cancer L Chesner, J Graff, F Polesso, A Smith, A Lundberg, M Sjoestroem, Z Xia, ... Cancer Research 83 (11_Supplement), B041-B041, 2023 | | 2023 |
| Abstract P1-07-07: Gene expression signatures and immunohistochemical subtypes add prognostic value to each other A Lundberg, LS Lindström, C Falato, JW Carlson, T Foukakis, K Czene, ... Cancer Research 77 (4_Supplement), P1-07-07-P1-07-07, 2017 | | 2017 |
Nicholas P. TobinKarolinska Institutet and University Hospital在 ki.se 的电子邮件经过验证
